Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2012

01.07.2012 | Article

The effect of diabetic control status on the clinical features of pulmonary tuberculosis

verfasst von: S. W. Park, J. W. Shin, J. Y. Kim, I. W. Park, B. W. Choi, J. C. Choi, Y. S. Kim

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to determine whether control status of diabetes mellitus influences clinical and radiographic manifestations and treatment responses in patients with tuberculosis (TB). The medical records of 492 patients who started anti-TB medication between January 2005 and December 2009 were retrospectively reviewed. Diabetes was diagnosed in 124 patients (25.2%). Of these, 74 (59.7%) were uncontrolled (HbA1C ≥7.0), 25 (20.2%) were controlled (HbA1C <7.0), and HbA1C levels were not assessed in the remaining 25 (20.2%). There were no differences in clinical symptoms between diabetics and non-diabetics, regardless of diabetes control status. There were also no differences in radiographic findings or AFB results between controlled diabetics and non-diabetics. However, uncontrolled diabetics had more cavitary lesions (p = 0.008) and higher positive smear rates (p < 0.001) compared with non-diabetics. After adjustment for age, cavities and positive smears before initiation of treatment, uncontrolled diabetes was a significant risk factor for a positive sputum culture at 2 months (odds ratio, 4.316; 95% CI, 1.306–14.267; p = 0.017). Uncontrolled diabetics seem to have more cavities, higher positive smear rates and lack of culture conversion after two months of therapy. Therefore, TB patients with uncontrolled diabetes should be carefully managed and treated.
Literatur
1.
Zurück zum Zitat Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S, Drobniewski F (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332(7533):85–87PubMedCrossRef Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S, Drobniewski F (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332(7533):85–87PubMedCrossRef
2.
Zurück zum Zitat Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152PubMedCrossRef Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152PubMedCrossRef
3.
Zurück zum Zitat Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M (2001) Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 68(6):595–600PubMedCrossRef Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M (2001) Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 68(6):595–600PubMedCrossRef
4.
Zurück zum Zitat Berger G, Zuleger F (1951) Diabetes mellitus and pulmonary tuberculosis in the postwar years. Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin 6(2):66–80PubMed Berger G, Zuleger F (1951) Diabetes mellitus and pulmonary tuberculosis in the postwar years. Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin 6(2):66–80PubMed
5.
Zurück zum Zitat Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, Huang MS (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 137(2):203–210PubMedCrossRef Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, Huang MS (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 137(2):203–210PubMedCrossRef
6.
Zurück zum Zitat Weaver RA (1974) Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients. Am Rev Respir Dis 109(1):162–163PubMed Weaver RA (1974) Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients. Am Rev Respir Dis 109(1):162–163PubMed
7.
Zurück zum Zitat Hadlock FP, Park SK, Awe RJ, Rivera M (1980) Unusual radiographic findings in adult pulmonary tuberculosis. AJR Am J Roentgenol 134(5):1015–1018PubMed Hadlock FP, Park SK, Awe RJ, Rivera M (1980) Unusual radiographic findings in adult pulmonary tuberculosis. AJR Am J Roentgenol 134(5):1015–1018PubMed
8.
Zurück zum Zitat Segarra F, Sherman DS, Rodriguez-Aguero J (1963) Lower lung field tuberculosis. Am Rev Respir Dis 87:37–40PubMed Segarra F, Sherman DS, Rodriguez-Aguero J (1963) Lower lung field tuberculosis. Am Rev Respir Dis 87:37–40PubMed
9.
Zurück zum Zitat Guler M, Unsal E, Dursun B, Aydln O, Capan N (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235PubMedCrossRef Guler M, Unsal E, Dursun B, Aydln O, Capan N (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61(2):231–235PubMedCrossRef
10.
Zurück zum Zitat Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79PubMed Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10(1):74–79PubMed
11.
Zurück zum Zitat Restrepo BI, Fisher-Hoch SP, Smith B, Jeon S, Rahbar MH, McCormick JB (2008) Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544PubMed Restrepo BI, Fisher-Hoch SP, Smith B, Jeon S, Rahbar MH, McCormick JB (2008) Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. Am J Trop Med Hyg 79(4):541–544PubMed
12.
Zurück zum Zitat Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435PubMedCrossRef Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45(4):428–435PubMedCrossRef
13.
Zurück zum Zitat Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639PubMed Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639PubMed
14.
Zurück zum Zitat Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H (2007) Tuberculosis susceptibility of diabetic mice. Am J Res Cell Mol Biol 37(5):518–524CrossRef Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H (2007) Tuberculosis susceptibility of diabetic mice. Am J Res Cell Mol Biol 37(5):518–524CrossRef
15.
Zurück zum Zitat Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, Cortes-Penfield N, McCormick JB (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641PubMedCrossRef Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, Cortes-Penfield N, McCormick JB (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47(5):634–641PubMedCrossRef
16.
Zurück zum Zitat Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494PubMedCrossRef Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167(12):1486–1494PubMedCrossRef
17.
Zurück zum Zitat Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553PubMedCrossRef Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553PubMedCrossRef
18.
Zurück zum Zitat Summary of revisions for the 2010 Clinical Practice Recommendations (2010) Diabetes Care 33(Suppl 1):S3 Summary of revisions for the 2010 Clinical Practice Recommendations (2010) Diabetes Care 33(Suppl 1):S3
19.
Zurück zum Zitat Leung EC, Leung CC, Tam CM (2007) Delayed presentation and treatment of newly diagnosed pulmonary tuberculosis patients in Hong Kong. Hong Kong Med J 13(3):221–227PubMed Leung EC, Leung CC, Tam CM (2007) Delayed presentation and treatment of newly diagnosed pulmonary tuberculosis patients in Hong Kong. Hong Kong Med J 13(3):221–227PubMed
20.
Zurück zum Zitat Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R (2000) Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 49(9):1451–1458PubMedCrossRef Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R (2000) Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 49(9):1451–1458PubMedCrossRef
21.
Zurück zum Zitat MacRury SM, Gemmell CG, Paterson KR, MacCuish AC (1989) Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 42(11):1143–1147PubMedCrossRef MacRury SM, Gemmell CG, Paterson KR, MacCuish AC (1989) Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 42(11):1143–1147PubMedCrossRef
22.
Zurück zum Zitat Sugawara I, Yamada H, Mizuno S (2004) Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204(2):135–145PubMedCrossRef Sugawara I, Yamada H, Mizuno S (2004) Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204(2):135–145PubMedCrossRef
23.
Zurück zum Zitat Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, Nelwan RH, Netea MG, van Crevel R (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27(2):97–103PubMedCrossRef Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, van der Meer JW, Nelwan RH, Netea MG, van Crevel R (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27(2):97–103PubMedCrossRef
24.
Zurück zum Zitat Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Anuar AK (2005) Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J Trop Med Public Health 36(Suppl 4):213–220PubMed Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Anuar AK (2005) Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J Trop Med Public Health 36(Suppl 4):213–220PubMed
25.
Zurück zum Zitat Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, McCormick JB (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 135(3):483–491PubMedCrossRef Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, McCormick JB (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 135(3):483–491PubMedCrossRef
26.
Zurück zum Zitat Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI (2008) Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 40(11–12):888–893PubMedCrossRef Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI (2008) Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 40(11–12):888–893PubMedCrossRef
27.
Zurück zum Zitat Sosman MC, Steidl JH (1927) Diabetic tuberculosis. Am J Roentgenol 17:625–629 Sosman MC, Steidl JH (1927) Diabetic tuberculosis. Am J Roentgenol 17:625–629
28.
Zurück zum Zitat Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO, Shaikh MA (2003) Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 7(1):58–64PubMed Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO, Shaikh MA (2003) Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis 7(1):58–64PubMed
29.
Zurück zum Zitat Wang JY, Lee LN, Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 9(7):777–783PubMed Wang JY, Lee LN, Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 9(7):777–783PubMed
30.
Zurück zum Zitat Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201PubMed Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201PubMed
31.
Zurück zum Zitat Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242PubMedCrossRef Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP (1999) Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 79(4):235–242PubMedCrossRef
32.
Zurück zum Zitat Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, Saito A (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64PubMedCrossRef Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, Saito A (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139(1):57–64PubMedCrossRef
33.
Zurück zum Zitat Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT (2001) Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther 69(6):400–406PubMedCrossRef Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT (2001) Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther 69(6):400–406PubMedCrossRef
Metadaten
Titel
The effect of diabetic control status on the clinical features of pulmonary tuberculosis
verfasst von
S. W. Park
J. W. Shin
J. Y. Kim
I. W. Park
B. W. Choi
J. C. Choi
Y. S. Kim
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1443-3

Weitere Artikel der Ausgabe 7/2012

European Journal of Clinical Microbiology & Infectious Diseases 7/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.